MicroRNA‑93 is overexpressed and induces apoptosis in glaucoma trabecular meshwork cells

Wang,Yansa; Li,Fenghua; Wang,Shuyun

doi:10.3892/mmr.2016.5938

MicroRNA‑93 is overexpressed and induces apoptosis in glaucoma trabecular meshwork cells

Authors:
- Yansa Wang
- Fenghua Li
- Shuyun Wang
View Affiliations

Affiliations: Department of Ophthalmology, Linyi People's Hospital, Linyi, Shandong 276000, P.R. China
Published online on: November 14, 2016 https://doi.org/10.3892/mmr.2016.5938
Pages: 5746-5750

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Glaucoma is an optic neuropathy and a major cause of blindness globally. Trabecular meshwork cells are important in maintaining aqueous humor flow, the dysfunction of which tends to induce glaucoma. As important regulators of gene expression, microRNAs may be crucial in regulating trabecular meshwork cells. The present study aimed to reveal the effect of microRNA‑93 (miR‑93) on glaucoma trabecular meshwork (GTM) cell apoptosis. The expression levels of miR‑93 were compared between human trabecular meshwork (HTM) cells and GTM cells. The expression of miR‑93 was inhibited and increased by transfecting the cells with a lentivirus containing its specific inhibitor sponge and expression vector to investigate changes in GTM cell viability and apoptosis. Alterations in the protein expression of nuclear factor erythroid 2‑like 2 (NFE2L2) were also examined to elucidate the possible mechanism underlying the effects of miR‑93. The results showed a marked promotion in the expression of miR‑93 in the GTM cells, compared with the HTM cells (P<0.01). GTM cell viability was increased and its apoptosis was inhibited by transfection with the miR‑93 sponge (P<0.01 and P<0.001, respectively), whereas the overexpression of miR‑93 abrogated these effects (P<0.05 and P<0.0001, respectively). The expression of NFE2L2, a possible target of miR‑93, was promoted by transfection with the miR‑93 sponge (P<0.01) and was inhibited in the cells overexpressing miR‑93 (P<0.01). Therefore, miR‑93 was capable of inhibiting viability and inducing apoptosis of the GTM cells, which was achieved via the suppression of NFE2L2. These results elucidated the pro‑apoptotic effects of miR‑93 in GTM cells and its possible functional mechanism, providing potential therapeutic targets for the treatment of glaucoma.

View Figures

View References

1	Kingman S: Glaucoma is second leading cause of blindness globally. Bull World Health Organ. 82:887–888. 2004.PubMed/NCBI
2	Quigley HA: Glaucoma. Lancet. 377:1367–1377. 2011. View Article : Google Scholar : PubMed/NCBI
3	Gasiorowski JZ and Russell P: Biological properties of trabecular meshwork cells. Exp Eye Res. 88:671–675. 2009. View Article : Google Scholar : PubMed/NCBI
4	Mozaffarieh M, Grieshaber MC and Flammer J: Oxygen and blood flow: Players in the pathogenesis of glaucoma. Mol Vis. 14:224–233. 2008.PubMed/NCBI
5	Tektas OY and Lütjen-Drecoll E: Structural changes of the trabecular meshwork in different kinds of glaucoma. Exp Eye Res. 88:769–775. 2009. View Article : Google Scholar : PubMed/NCBI
6	Hausser J and Zavolan M: Identification and consequences of miRNA-target interactions-beyond repression of gene expression. Nat Rev Genet. 15:599–612. 2014. View Article : Google Scholar : PubMed/NCBI
7	Asirvatham AJ, Magner WJ and Tomasi TB: miRNA regulation of cytokine genes. Cytokine. 45:58–69. 2009. View Article : Google Scholar : PubMed/NCBI
8	Wu L and Belasco JG: Let me count the ways: Mechanisms of gene regulation by miRNAs and siRNAs. Mol Cell. 29:1–7. 2008. View Article : Google Scholar : PubMed/NCBI
9	Georges M, Coppieters W and Charlier C: Polymorphic miRNA-mediated gene regulation: Contribution to phenotypic variation and disease. Curr Opin Genet Dev. 17:166–176. 2007. View Article : Google Scholar : PubMed/NCBI
10	Das J, Podder S and Ghosh TC: Insights into the miRNA regulations in human disease genes. BMC Genomics. 15:10102014. View Article : Google Scholar : PubMed/NCBI
11	Luna C, Li G, Huang J, Qiu J, Wu J, Yuan F, Epstein DL and Gonzalez P: Regulation of trabecular meshwork cell contraction and intraocular pressure by miR-200c. PLoS One. 7:e516882012. View Article : Google Scholar : PubMed/NCBI
12	Li G, Luna C, Qiu J, Epstein DL and Gonzalez P: Alterations in microRNA expression in stress-induced cellular senescence. Mech Ageing Dev. 130:731–741. 2009. View Article : Google Scholar : PubMed/NCBI
13	Li G, Luna C, Qiu J, Epstein DL and Gonzalez P: Targeting of integrin beta1 and kinesin 2alpha by microRNA 183. J Biol Chem. 285:5461–5471. 2010. View Article : Google Scholar : PubMed/NCBI
14	Yu XF, Zou J, Bao ZJ and Dong J: miR-93 suppresses proliferation and colony formation of human colon cancer stem cells. World J Gastroenterol. 17:4711–4717. 2011. View Article : Google Scholar : PubMed/NCBI
15	Du L, Schageman JJ, Subauste MC, Saber B, Hammond SM, Prudkin L, Wistuba II, Ji L, Roth JA, Minna JD and Pertsemlidis A: miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. Mol Cancer Res. 7:1234–1243. 2009. View Article : Google Scholar : PubMed/NCBI
16	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
17	Singh B, Ronghe AM, Chatterjee A, Bhat NK and Bhat HK: MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis. Carcinogenesis. 34:1165–1172. 2013. View Article : Google Scholar : PubMed/NCBI
18	Izzotti A, Saccà SC, Longobardi M and Cartiglia C: Mitochondrial damage in the trabecular meshwork of patients with glaucoma. Arch Ophthalmol. 128:724–730. 2010. View Article : Google Scholar : PubMed/NCBI
19	Saccà SC and Izzotti A: Focus on molecular events in the anterior chamber leading to glaucoma. Cell Mol Life Sci. 71:2197–2218. 2014. View Article : Google Scholar : PubMed/NCBI
20	Kensler TW, Wakabayashi N and Biswal S: Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol. 47:89–116. 2007. View Article : Google Scholar : PubMed/NCBI
21	He X, Lin GX, Chen MG, Zhang JX and Ma Q: Protection against chromium (VI)-induced oxidative stress and apoptosis by Nrf2. Recruiting Nrf2 into the nucleus and disrupting the nuclear Nrf2/Keap1 association. Toxicol Sci. 98:298–309. 2007. View Article : Google Scholar : PubMed/NCBI
22	Vargas MR, Pehar M, Cassina P, Beckman JS and Barbeito L: Increased glutathione biosynthesis by Nrf2 activation in astrocytes prevents p75NTR-dependent motor neuron apoptosis. J Neurochem. 97:687–696. 2006. View Article : Google Scholar : PubMed/NCBI
23	Singh A, Boldin-Adamsky S, Thimmulappa RK, Rath SK, Ashush H, Coulter J, Blackford A, Goodman SN, Bunz F, Watson WH, et al: RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy. Cancer Res. 68:7975–7984. 2008. View Article : Google Scholar : PubMed/NCBI
24	Narasimhan M, Mahimainathan L, Rathinam ML, Riar AK and Henderson GI: Overexpression of Nrf2 protects cerebral cortical neurons from ethanol-induced apoptotic death. Mol Pharmacol. 80:988–999. 2011. View Article : Google Scholar : PubMed/NCBI
25	Son YO, Pratheeshkumar P, Roy RV, Hitron JA, Wang L, Zhang Z and Shi X: Nrf2/p62 signaling in apoptosis resistance and its role in cadmium-induced carcinogenesis. J Biol Chem. 289:28660–28675. 2014. View Article : Google Scholar : PubMed/NCBI
26	Bhakkiyalakshmi E, Shalini D, Sekar TV, Rajaguru P, Paulmurugan R and Ramkumar KM: Therapeutic potential of pterostilbene against pancreatic beta-cell apoptosis mediated through Nrf2. Br JPharmacol. 171:1747–1757. 2014. View Article : Google Scholar
27	Long J, Wang Y, Wang W, Chang BH and Danesh FR: Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions. J Biol Chem. 285:23457–23465. 2010. View Article : Google Scholar : PubMed/NCBI
28	Fu X, Tian J, Zhang L, Chen Y and Hao Q: Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells. FEBS Lett. 586:1279–1286. 2012. View Article : Google Scholar : PubMed/NCBI
29	Yang IP, Tsai HL, Hou MF, Chen KC, Tsai PC, Huang SW, Chou WW, Wang JY and Juo SH: MicroRNA-93 inhibits tumor growth and early relapse of human colorectal cancer by affecting genes involved in the cell cycle. Carcinogenesis. 33:1522–1530. 2012. View Article : Google Scholar : PubMed/NCBI
30	Goto Y, Kojima S, Nishikawa R, Enokida H, Chiyomaru T, Kinoshita T, Nakagawa M, Naya Y, Ichikawa T and Seki N: The microRNA-23b/27b/24-1 cluster is a disease progression marker and tumor suppressor in prostate cancer. Oncotarget. 5:7748–7759. 2014. View Article : Google Scholar : PubMed/NCBI
31	Lattanzi A, Gentner B, Corno D, Di Tomaso T, Mestdagh P, Speleman F, Naldini L and Gritti A: Dynamic activity of miR-125b and miR-93 during murine neural stem cell differentiation in vitro and in the Subventricular Zone Neurogenic Niche. PLoS One. 8:e674112013. View Article : Google Scholar : PubMed/NCBI
32	Gentner B, Visigalli I, Hiramatsu H, Lechman E, Ungari S, Giustacchini A, Schira G, Amendola M, Quattrini A, Martino S, et al: Identification of hematopoietic stem cell-specific miRNAs enables gene therapy of globoid cell leukodystrophy. Sci Transl Med. 2:58ra842010. View Article : Google Scholar : PubMed/NCBI
33	Tian B and Kaufman PL: A potential application of canaloplasty in glaucoma gene therapy. Transl Vis Sci Technol. 2pii(2)2013.
34	Aktas Z, Tian B, McDonald J, Yamamato R, Larsen C, Kiland J, Kaufman PL and Rasmussen CA: Application of canaloplasty in glaucoma gene therapy: Where are we? J Ocul Pharmacol Ther. 30:277–282. 2014. View Article : Google Scholar : PubMed/NCBI